Blood

Mixed phenotype acute leukemia

ORPHA:530995 ↗

Search all Mixed phenotype acute leukemia trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

132

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

30 Jul 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor National Cancer Institute (NCI)Where United States, Puerto Rico (114 sites)Studying Asparaginase Erwinia chrysanthemi, Biospecimen CollectionUpdated 2 Sept 2026

See details

RecruitingPhase 1 / Phase 2NCT05322850

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Sponsor University of FloridaWhere United States (4 sites)Studying Orca-QUpdated 1 Sept 2026

See details

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor PedAL BCU, LLCWhere United States, Australia, Canada +2 (184 sites)Studying Biospecimen CollectionUpdated 25 Aug 2026

See details

RecruitingPhase 3NCT03959085

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Sponsor Children's Oncology GroupWhere United States, Australia, Canada +2 (231 sites)Studying Biospecimen Collection, BlinatumomabUpdated 25 Aug 2026

See details

RecruitingNot applicableNCT07094750

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Sponsor Fred Hutchinson Cancer CenterWhere United States (1 site)Studying Biospecimen Collection, Bone Marrow CollectionUpdated 12 Aug 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 43 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Australia Canada New Zealand Puerto Rico United States

Keep watching

Get an email when a new Mixed phenotype acute leukemia study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:530995 ↗

About Mixed phenotype acute leukemia

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).